TSH Biopharm Corporation Limited

8432

TW0008432006

Pharmaceuticals

End-of-day quote Taipei Exchange Other stock markets 03:30:00 18/06/2024 am IST			5-day change	1st Jan Change
64.4 ^TWD	+1.58%		-3.45%	+28.03%

24/05	TSH Biopharm Corporation Limited Announces Appointment of Two Additional Members of Sustainable Development Committee	CI
24/05	TSH Biopharm Corporation Limited Announces Appointment of Two Additional Members of Audit Committee	CI

TSH Biopharm Corporation Limited Announces Board Changes

May 28, 2020 at 10:08 pm IST

TSH Biopharm Corporation Limited approved to appoint Lin, Chuan, Carl Hsiao, Chuang, Chao-I and Chou, Kang-Chi as directors.

Latest news about TSH Biopharm Corporation Limited

TSH Biopharm Corporation Limited Announces Appointment of Two Additional Members of Sustainable Development Committee	24/05	CI
TSH Biopharm Corporation Limited Announces Appointment of Two Additional Members of Audit Committee	24/05	CI
TSH Biopharm Corporation Limited Appoints Two Additional Independent Directors	24/05	CI
TSH Biopharm Corporation Limited Announces Cash Dividend for the Year 2023, Payable on July 12, 2024	24/05	CI
TSH Biopharm Corporation Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	07/05	CI
TSH Biopharm Corporation Limited Announces Directorate Changes on April 1, 2024	11/03	CI
TSH Biopharm Corporation Limited Appoints Jung-Liang Kao as CFO on April 1, 2024	11/03	CI
TSH Biopharm Corporation Limited agreed to acquire an unknown stake in TOP Pharm. Medicalware Company Limited from Gu An Engineering Consultants Co., Ltd., Kao Tuan International Consulting Co., Ltd., ANIMATO INTERNATIONAL COMPANY, Shen Feng Co., Ltd. and others for TWD 257.1 million.	11/03	CI
TSH Biopharm Corporation Limited agreed to acquire 51% stake in TOP Biological Technology Company Limited from Shen Feng Co., Ltd., Gu An Engineering Consultants Co., Ltd., Kao Tuan International Consulting Co., Ltd. ANIMATO INTERNATIONAL COMPANY and others for TWD 44.3 million.	11/03	CI
TSH Biopharm Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2023	28/02	CI
TSH Biopharm Corporation Limited Announces the Change of Financial Officer, Effective on January 1, 2024	14/12	CI
TSH Biopharm Corporation Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	03/11	CI
TSH Biopharm Corporation Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	04/23/04	CI
Tsh Biopharm Corporation Limited Announces the Change of Audit Committee Members	25/23/25	CI
Tsh Biopharm Corporation Limited Announces Dividend for the Year 2022, Payable on July 14, 2023	25/23/25	CI
TSH Biopharm Corporation Limited Reports Earnings Results for the First Quarter Ended March 31, 2023	04/23/04	CI
TSH Biopharm Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2022	10/23/10	CI
TSH Biopharm Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2022	10/23/10	CI
TSH Biopharm Corporation Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	03/22/03	CI
TSH Biopharm Corporation Limited Announces Board Appointments	04/22/04	CI
TSH Biopharm Corporation Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	04/22/04	CI
TSH Biopharm Corporation Limited Appoints Yaw-Bin, Huang as Audit Committee Member	25/22/25	CI
TSH Biopharm Corporation Limited Announces Cash Dividends, Payable on July 8, 2022	25/22/25	CI
TSH Biopharm Corporation Limited Reports Earnings Results for the First Quarter Ended March 31, 2022	05/22/05	CI
TSH Biopharm Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2021	04/22/04	CI

Chart TSH Biopharm Corporation Limited

Duration

Period

More charts

Tsh biopham corporation ltd. is a Taiwan-based company principally engaged in the manufacturing and distribution of medical preparations. The Company primarily provides medicines for cardiovascular, including Amtrel, Rytmonorm, Licodin, Isormol and ISOPTIN SR; medicines for intestines and stomach, including MOPRIDE, Catilon, Gastro-Timelet and Ribarin, and medicines for central nervous, including Aleviatin, Lonine and Lacoxa SR. The Company distributes its products mainly in domestic markets.

Sector

Pharmaceuticals

Calendar

01/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
TSH BIOPHARM CORPORATION LIMITED	+28.03%	7.63Cr
ELI LILLY AND COMPANY	+52.93%	80TCr
NOVO NORDISK A/S	+40.52%	63TCr
JOHNSON & JOHNSON	-7.08%	35TCr
MERCK & CO., INC.	+17.40%	32TCr
ABBVIE INC.	+10.58%	30TCr
ASTRAZENECA PLC	+15.15%	24TCr
ROCHE HOLDING AG	+1.68%	23TCr
AMGEN INC.	+6.24%	16TCr
PFIZER, INC.	-4.79%	16TCr